Lannett (LCI), FDA Reach Agreement Over SPA for C-Topical Phase III
Go back to Lannett (LCI), FDA Reach Agreement Over SPA for C-Topical Phase III| LANNETT COMP (NYSE: LCI) | Delayed: 0.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $44.49 | |||
| Open | $117.23 | 52 Week Low | $16.75 | |||
| Day High | $0.69 | P/E | 1.35 | |||
| Day Low | $0.69 | EPS | $0.51 | |||
| Volume | 584,457 | |||||
